Jack Welch

Jack Welch is the Chief Medical Officer at Oncorena AB, a Swedish pharma company focused on developing a treatment for metastatic renal cancer. Jack has a strong background in oncology, having held positions at companies like Theradex Oncology and the National Cancer Institute. With a Doctor of Medicine and PhD in Pharmacology, Jack has a wealth of experience in leading international clinical research collaborations and overseeing clinical trials in various cancer specialties. Jack also has experience in pediatric hematology-oncology and laboratory automation.